Cite
MLA Citation
Kosmas Kretsos et al.. “Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study.” Clinical pharmacology in drug development, vol. 3, no. 5, n.d., pp. 388–395. http://access.bl.uk/ark:/81055/vdc_100024914266.0x000011